Progress in Cardiovascular Diseases
Volume 45, Issue 2 , Pages 81-114 , September 2002

Ion channels in pulmonary arterial hypertension

References 

  1. Yuan JX-J, Rubin LJ. Pathophysiology of pulmonary hypertension. In:  Scharf SM editors. Respiratory-Circulatory Interactions in Health and Disease. New York, NY: Marcel Dekker; 2001;p. 447–477
  2. Mohrman DE, Heller LJ. Homeostasis and cardiovascular transport. In: ed 3.  Mohrman DE,  Heller LJ editor. Cardiovascular Physiology. Chap 1:McGraw-Hill; 1991;p. 1–16
  3. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997;336:111–117
  4. Rich S. Executive summary of the World Symposium on primary pulmonary hypertension, 1999. Available at http://www.who.int/ncd/cvd/pph.htmlNovember 20, 2001; Accessed
  5. Deng Z, Morse JH, Slager SL, et al.  Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet. 2000;67:737–744
  6. Yuan JX-J, Aldinger AM, Juhaszova M, et al.  Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. Circulation. 1998;98:1400–1406
  7. Eddahibi S, Humbert M, Fadel E, et al.  Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest. 2001;108:1141–1150
  8. Stenmark KR, Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol. 1997;59:89–144
  9. Hishikawa K, Nakaki T, Marumo T, et al.  Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells. J Clin Invest. 1994;93:1975–1980
  10. Kolpakov V, Rekhter MD, Gordon D, et al.  Effect of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery, analysis of the role of individual cell types. Circ Res. 1995;77:823–831
  11. Yuan X-J, Wang J, Juhaszova M, et al.  Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 1998;274:L621–L635
  12. Eisenberg PR, Lucore C, Kaufman L, et al.  Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. Circulation. 1990;82:841–847
  13. Welsh CH, Hassell KL, Badesch DB, et al.  Coagualtion and fibrinolytic profiles in patients with severe pulmonary hypertension. Chest. 1996;110:710–717
  14. Christman BW, McPherson CD, Newman JH, et al.  An imbalance between the excretion of thromboxane and prostacyclin metabos in pulmonary hypertension. N Engl J Med. 1992;327:70–75
  15. Cacoub P, Dorent R, Carayon A. Thromboxane and prostacyclin metabos in pulmonary hypertension. N Engl J Med. 1992;327:1456–1457
  16. Geggel RL, Carvalho AC, Hoyer LW, et al.  Von Willebrand factor abnormalities in primary pulmonary hypertension. Am Rev Respir Dis. 1987;135:294–299
  17. Lopes AAB, Maeda NY. Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension. Chest. 1998;114:1276–1282
  18. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature. 1994;372:231–236
  19. Allbritton NL, Oancea E, Kuhn MA, et al.  Source of nuclear calcium signals. Proc Natl Acad Sci USA. 1994;91:12458–12462
  20. Hardingham GE, Chawla S, Johnson CM, et al.  Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature. 1997;385:260–265
  21. Means AR. Calcium calmodulin and cell cycle regulation. FEBS Lett. 1994;347:1–4
  22. Berridge MJ. Inositol triphosphate and calcium signaling. Nature. 1993;361:315–325
  23. Chao TS, Byron KL, Lee KM, et al.  Activation of MAP kinases by calcium-dependent and calcium-independent pathways. Stimulation by thapsigargin and epidermal growth factor. J Biol Chem. 1992;267:19876–19883
  24. Golovina VA, Platoshyn O, Bailey CL, et al.  Upregulated TRP and enhanced capacitative Ca2+ entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol. 2001;280:H746–H755
  25. Platoshyn O, Golovina VA, Bailey CL, et al.  Sustained membrane depolarization and pulmonary artery smooth muscle cell proliferation. Am J Physiol Cell Physiol. 2000;279:C1540–C1549
  26. McDaniel SS, Platoshyn O, Wang J, et al.  Capacitative Ca2+ entry in agonist-induced pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol. 2001;280:L870–L880
  27. Mogami H, Kojima I. Stimulation of calcium entry is prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells. Biochem Biophys Res Commun. 1993;196:650–658
  28. Short AD, Bian J, Ghosh TK, et al.  Intracellular Ca2+ pool content is linked to control of cell growth. Proc Natl Acad Sci USA. 1993;90:4986–4990
  29. Blaustein MP. Physiological effects of endogenous ouabain: Control of intracellular Ca2+ stores and cell responsiveness. Am J Physiol Cell Physiol. 1993;264:C1367–C1387
  30. Ganitkevich VYa, Isenberg G. Membrane potential modulates inositol 1,4,5-triphosphate-mediated Ca2+ transients in guinea-pig coronary myocytes. J Physiol (Lond). 1993;470:35–44
  31. Nelson MT, Patlak JB, Worley JF, et al.  Calcium channels, potassium channels and voltage dependence of arterial smooth muscle tone. Am J Physiol Cell Physiol. 1990;259:C3–C18
  32. Parekh AB, Penner R. Store depletion and calcium influx. Physiol Rev. 1997;77:901–930
  33. Tsien RW, Tsien RY. Calcium channels, stores, and oscillations. Annu Rev Cell Biol. 1990;6:715–760
  34. Hartong R, Villarreal FJ, Giordano F, et al.  Phorbol myristate acetate-induced hypertrophy of neonatal rat cardiac myocytes is associated with decreased sarcoplasmic reticulum Ca2+ ATPase (SERCA2) gene expression and calcium reuptake. J Mol Cell Cardiol. 1996;28:2467–2477
  35. Blaustein MP, Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev. 1999;79:763–854
  36. Fleischmann BK, Murray RK, Kotlikoff MI. Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells. Proc Natl Acad Sci USA. 1994;91:11914–11918
  37. Freichel M, Schweig U, Stauffenberger S, et al.  Store-operated cation channels in the heart and cells of the cardiovascular system. Cell Physiol Biochem. 1999;9:270–283
  38. Hansen PB, Jensen BL, Andreasen D, et al.  Differential expression of T-and L-type voltage dependent calcium channels in renal resistance vessels. Circ Res. 2001;89:630–638
  39. Sturek M, Hermsmeyer K. Calcium and sodium channels in spontaneously contracting vascular muscle cells. Science. 1986;233:475–478
  40. Muramatsu M, Tyler RC, Rodman DM, et al.  Possible role of T-type Ca2+ channels in L-NNA vasoconstriction of hypertensive rat lungs. Am J Physiol Heart Circ Physiol. 1997;272:H2616–H2621
  41. Nakamura Y, Ono H, Frohlich ED. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats. Hypertension. 1999;34:273–278
  42. Shimoda LA, Sham JSK, Shimoda TH, et al.  L-type Ca2+ channels, resting [Ca2+]i, and ET-1-induced responses in chronically hypoxic pulmonary myocytes. Am J Physiol Lung Cell Mol Physiol. 2000;279:L884–L894
  43. McCarron JG, Crichton CA, Langton PD, et al.  Myogenic contraction by modulation of voltage-dependent calcium currents in isolated rat cerebral arteries. J Physiol (Lond). 1997;498:371–379
  44. Beech DJ. Action of neurotransmitters and other messengers on Ca2+ channels and K+ channels in smooth muscle cells. Pharmacol Ther. 1997;73:91–119
  45. Scotland R, Vallance P, Ahluwalia A. Endothelin alters the reactivity of vasa vasorum: Mechanisms and implications for conduit vessel physiology and pathophysiology. Br J Pharmacol. 1999;28:1229–1234
  46. Putney JW, Broad LM, Braun F-J, et al.  Mechanisms of capacitative calcium entry. J Cell Sci. 2001;114:2223–2229
  47. Ng LC, Gurney AM. Store-operated channels mediate Ca2+ influx and contraction in rat pulmonary artery. Circ Res. 2001;89:923–929
  48. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol Cell Physiol. 1995;268:C799–C822
  49. Yuan X-J, Goldman WF, Tod ML, et al.  Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am J Physiol Lung Cell Mol Physiol. 1993;264:L116–L123
  50. Lesage F, Lazdunski M. Molecular and functional properties of two-pore-domain potassium channels. Am J Physiol Renal Physiol. 2000;279:F793–F801
  51. In:  Archer SL,  Rusch NJ editor. Potassium Channels in Cardiovascular Biology. New York, NY: Kluwer Academic/Plenum Press; 2001;
  52. Archer SL, Huang JMC, Reeve HL, et al.  Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia. Circ Res. 1996;78:431–442
  53. Gelband CH, Hume JR. Ionic currents in single smooth muscle cells of the canine renal artery. Circ Res. 1992;71:745–758
  54. Gelband CH, Ishikawa T, Post JM, et al.  Intracellular divalent cations block smooth muscle K+ channels. Circ Res. 1993;73:24–34
  55. Post JM, Gelband CH, Hume JR. Ca2+]i inhibition of K+ channels in canine pulmonary artery. Novel mechanism for hypoxia-induced membrane depolarization. Circ Res. 1995;77:131–139
  56. Yuan X-J, Wang J, Juhaszova M, et al.  Attenuated K+ channel gene transcription in primary pulmonary hypertension. The Lancet. 1998;351:726–727
  57. Coppock EA, Martens JR, Tamkun MM. Molecular basis of hypoxia-induced pulmonary vasoconstriction: Role of voltage-gated K+ channels. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1–L12
  58. Rettig J, Heinemann SH, Wunder F, et al.  Inactivation properties of voltage-gated K+ channels altered by presence of -subunit. Nature. 1994;369:289–294
  59. Clément-Chomienne O, Walsh MP, Cole WC. Angiotensin II activation of protein kinase C decreases delayed rectifier K+ current in rabbit vascular myocytes. J Physiol (Lond). 1996;495:689–700
  60. Shimoda LA, Sylvester JT, Booth GM, et al.  Inhibition of voltage-gated K+ currents by endothelin-1 in human pulmonary arterial myocytes. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1115–L1122
  61. Aiello EA, Malcolm AT, Walsh MP, et al.  β-Adrenoceptor activation and PKA regulate delayed rectifier K+ channels of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 1998;275:H448–H459
  62. Yuan X-J, Tod ML, Rubin LJ, et al.  NO hyperpolarizes pulmonary artery smooth muscle cells and decreases the intracellular Ca2+ concentration by activating voltage-gated K+ channels. Proc Natl Acad Sci USA. 1996;93:10489–10494
  63. Ahn DS, Hume JR. pH regulation of voltage-dependent K+ channels in canine pulmonary arterial smooth muscle cells. Pflügers Arch. 1997;433:758–765
  64. Evans AM, Clapp LH, Gurney AM. Augmentation by intracellular ATP of the delayed rectifier current independently of the glibenclamide-sensitive K-current in rabbit arterial myocytes. Br J Pharmacol. 1994;111:972–974
  65. Smirnov SV, Aaronson PI. Modulatory effects of arachidonic acid on the delayed rectifier K+ current in rat pulmonary arterial myocytes. Structural aspects and involvement of protein kinase C. Circ Res. 1996;79:20–31
  66. Yuan X-J. Voltage-gated K+ currents regulate resting membrane potential and [Ca2+]i in pulmonary arterial myocytes. Circ Res. 1995;77:370–378
  67. Knot HJ, Nelson MT. Regulation of membrane potential and diameter by voltage-dependent K+ channels in rabbit myogenic cerebral arteries. Am J Physiol Heart Circ Physiol. 1995;269:H348–H355
  68. Garcia-Calvo M, Knaus HG, McManus OB, et al.  Purification and reconstitution of the high-conductance calcium-activated potassium channel from tracheal smooth muscle. J Biol Chem. 1994;269:676–682
  69. Toro L, Wallner M, Meera P, et al.  Maxi-KCa, a unique member of the voltage-gated K channel superfamily. News Physiol Sci. 1998;13:112–117
  70. Brenner R, Jegla TJ, Wickenden A, et al.  Cloning and functional characterization of novel large conductance calcium-activated potassium channel β subunits, hKCNMB3 and hKCNMB4. J Bio Chem. 2000;275:6453–6461
  71. Uebele VN, Lagrutta A, Wade T, et al.  Cloning and functional expression of β-subunits of the large-conductance K+ channel. J Biol Chem. 2000;275:23211–23218
  72. Murphy ME, Brayden JE. Apamin-sensitive K+ channels mediate an endothelium-dependent hyperpolarization in rabbit mesenteric arteries. J Physiol (Lond). 1995;489:723–734
  73. Neylon CB, Lang RJ, Fu Y, et al.  Molecular cloning and characterization of the intermediate-conductance Ca2+-activated K+ channel in vascular smooth muscle: Relationship between KCa channel diversity and smooth muscle cell function. Circ Res. 1999;85:e33–e43
  74. Blanc E, Darbon H. Pharmacology of small-conductance, calcium-activated K+ channels. In:  Archer SL,  Rusch NJ editor. Potassium Channels in Cardiovascular Biology. New York, NY: Kluwer Academic/Plenum Press; 2001;p. 235–253
  75. Brayden JE, Nelson MT. Regulation of arterial tone by activation of Ca2+ dependent potassium channels. Science. 1992;256:532–535
  76. Jaggar JH, Porter VA, Lederer WJ, et al.  Calcium sparks in smooth muscle. Am J Physiol Cell Physiol. 2000;278:C235–C256
  77. Scornik FS, Toro L. U46619, a thromboxane A2 agonist, inhibits KCa channel activity from pig coronary artery. Am J Physiol Cell Physiol. 1992;262:C708–C713
  78. Toro L, Amador M, Stefani E. ANG-II inhibits Ca2+-activated potassium channels from coronary smooth muscle in lipid bilayers. Am J Physiol Heart Circ Physiol. 1990;258:H912–H915
  79. Archer SL, Huang JMC, Hampl V, et al.  Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Nat Acad Sci USA. 1994;91:7583–7587
  80. Bolotina VM, Najibi S, Palacino JJ, et al.  Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850–853
  81. Robertson BE, Schubert R, Hescheler J, et al.  cGMP-dependent protein kinase activates Ca-activated K+ channels in cerebral artery smooth muscle cells. Am J Physiol Cell Physiol. 1993;265:C299–C303
  82. White RE, Darkow DJ, Lang JLF. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. Circ Res. 1995;77:936–942
  83. Campbell WB, Gebremedhin D, Pratt PF, et al.  Identification of epoxyeicosatyrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415–423
  84. Clapp LH. Regulation of glibenclamide-sensitive K+ current by nucleotide phosphates in isolate rabbit pulmonary myocytes. Cardiovasc Res. 1995;30:460–468
  85. Quayle JM, Nelson MT, Standen NB. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev. 1997;77:1165–1232
  86. Wiener CM, Dunn A, Sylvester JT. ATP-dependent K+ channels modulate vasoconstrictor responses to severe hypoxia in isolated ferret lungs. J Clin Invest. 1991;88:500–504
  87. Quayle JM, McCarron JG, Brayden JE, et al.  Inward rectifier K+ currents in smooth muscle cells from rat resistance-sized cerebral arteries. Am J Physiol Cell Physiol. 1993;25:C1363–C1370
  88. Hirst GDS, Silverberg GD, van Helden DF. The action potential and underlying ionic currents in proximal rat middle cerebral arterioles. J Physiol (Lond). 1986;371:289–304
  89. Buckler KJ, Williams BA, Honore E. An oxygen-, acid- and anaesthetic-sensitive TASK-like background potassium channel in rat arterial chemoreceptor cells. J Physiol (Lond). 2000;525:135–142
  90. Platoshyn O, Mandegar M, Yu Y, et al.  Functional ion channels in human pulmonary artery smooth muscle cells. Biophys J. 2002;82:249a
  91. Okabe K, Kitamura K, Kuriyama H. The existence of a highly tetrodotoxin sensitive Na channel in freshly dispersed smooth muscle cells of the rabbit main pulmonary artery. Pflügers Arch. 1988;411:423–428
  92. Van Renterghem C, Lazdunski M. A new non-voltage-dependent, epithelial-like Na+ channel in vascular smooth muscle cells. Pflügers Arch. 1991;419:401–408
  93. Fernández del Pozo B, Pérez-Vizcaíno F, Fernández C, et al.  Effects of several class I antiarrhythmic drugs on isolated rat aortic vascular smooth muscle. Gen Pharmacol. 1997;29:539–543
  94. Boccara G, Choby C, Frapier JM, et al.  Regulation of Ca2+ homeostasis by atypical Na+ currents in cultured human coronary myocytes. Circ Res. 1999;85:606–613
  95. Aickin CC, Brading AF. Measurement of intracellular chloride in guinea-pig vas deferens by ion analysis, 36chloride efflux and micro-electrodes. J Physiol (Lond). 1982;326:139–154
  96. Clapp LH, Turner JL, Kozlowski RZ. Ca2+ activated Cl− currents in pulmonary arterial myocytes. Am J Physiol Heart Circ Physiol. 1996;270:H1577–H1584
  97. Large WA, Wang Q. Characteristics and physiological role of the Ca2+-activated Cl− conductance in smooth muscle. Am J Physiol Cell Physiol. 1996;271:C435–C454
  98. Yuan X-J. Role of calcium-activated chloride current in regulating pulmonary vascular tone. Am J Physiol Lung Cell Mol Physiol. 1997;272:L959–L968
  99. Hogg RC, Wang Q, Large WA. Action of niflumic acid on evoked and spontaneous calcium-activated chloride and potassium currents in smooth muscle cells from rabbit portal vein. Br J Pharmacol. 1994;112:977–984
  100. Leblanc N, Leung PM. Indirect stimulation of Ca2+-activated Cl− current by Na+/Ca2+ exchange in rabbit portal vein smooth muscle. Am J Physiol Heart Circ Physiol. 1995;268:H1906–H1917
  101. ZhuGe R, Sims SM, Tuft RA, et al.  Ca2+ sparks activate K+ and Cl− channels, resulting in spontaneous transient currents in guinea-pig tracheal myocytes. J Physiol (Lond). 1998;513:711–718
  102. Salter KJ, Turner JL, Albarwani S, et al.  Ca2+-activated Cl− and K+ channels and their modulation by endothelin-1 in rat pulmonary arterial smooth muscle cells. Exp Physiol. 1995;80:815–824
  103. Nelson MT, Standen NB, Brayden JE, et al.  Noradrenaline contracts arteries by activating voltage-dependent calcium channels. Nature. 1988;336:382–385
  104. Greenwood IA, Large WA. Properties of a Cl− current activated by cell swelling in rabbit portal vein vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 1998;275:H1524–H1532
  105. Sweeney M, Yuan JX-J. Hypoxic pulmonary vasoconstriction: role of voltage-gated potassium channels. Respir Res. 2000;1:40–48
  106. Yuan X-J, Bright RT, Aldinger AM, et al.  Nitric oxide inhibits serotonin-induced calcium release in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 1997;272:L44–L50
  107. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res. 1998;82:1111–1129
  108. Rabinovitch M. Elastase and the pathobiology of unexplained pulmonary hypertension. Chest. 1998;114:213S–224S
  109. Yu SP, Choi DW. Ions, cell volume, and apoptosis. Proc Natl Acad Sci USA. 2000;97:9360–9362
  110. Lang F, Busch GL, Ritter M, et al.  Functional significance of cell volume regulatory mechanisms. Physiol Rev. 1998;78:247–306
  111. Maeno E, Ishizaki Y, Kanaseki T, et al.  Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci USA. 2000;97:9487–9492
  112. Dallaporta B, Hirsch T, Susin SA, et al.  Potassium leakage during the apoptotic degradation phase. J Immunol. 1998;160:5605–5615
  113. Bortner CD, Hughes FM, Cidlowski JA. A primary role for K+ and Na+ efflux in the activation of apoptosis. J Biol Chem. 1997;272:32436–32442
  114. Bortner CD, Cidlowski JA. Caspase independent/dependent regulation of K+, cell shrinkage, and mitochondrial mmbrane potential during lymphocyte apoptosis. J Biol Chem. 1999;274:21953–21962
  115. Hughes FM, Bortner CD, Purdy GD, et al.  Intracellular K+ suppresses the activation of apoptosis in lymphocytes. J Biol Chem. 1997;272:30567–30576
  116. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281:1312–1316
  117. Krick S, Platoshyn O, Sweeney M, et al.  Activation of K+ channels induces apoptosis in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2001;280:C970–C979
  118. Ekhterae D, Platoshyn O, Krick S, et al.  Bcl-2 decreases voltage-gated K+ channel activity and enhances survival in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2001;281:C157–C165
  119. Kroemer G, Reed JC. Mitochondrial control of cell death. Nature Med. 2000;6:513–519
  120. Krick S, Platoshyn O, McDaniel SS, et al.  Augmented K+ currents and mitochondrial membrane depolarization in pulmonary artery myocyte apoptosis. Am J Physiol Lung Cell Mol Physiol. 2001;281:L887–L894
  121. Marshall C, Marshall BE. Hypoxic pulmonary vasoconstriction is not endothelium dependent. Proc Soc Exp Biol Med. 1992;201:267–270
  122. Yuan X-J, Tod ML, Rubin LJ, et al.  Contrasting effects of hypoxia on tension in rat pulmonary and mesenteric arteries. Am J Physiol. 1990;259(2 Pt 2):H281–H289
  123. Murray TR, Chen L, Marshall BE, et al.  Hypoxic contraction of cultured pulmonary vascular smooth muscle cells. Am J Respir Cell Mol Biol. 1990;3:457–465
  124. Lopez-Lopez J, Gonzalez C, Urena J, et al.  Low PO2 selectively inhibits K channel activity in chemoreceptor cells of the mammalian carotid body. J Gen Physiol. 1989;93:1001–1015
  125. Archer SL, Souil E, Dinh-Xuan AT, et al.  Molecular identification of the role of voltage-gated K+ channels Kv1.5 and Kv2.1 in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest. 1998;101:2319–2330
  126. Franco-Obregón A, López-Barneo J. Low PO2 inhibits calcium channel activity in arterial smooth muscle cells. Am J Physiol Heart Circ Physiol. 1996;271:H2290–H2299
  127. Archer SL, Huang J, Henry T, et al.  A redox-based O2 sensor in rat pulmonary vasculature. Circ Res. 1993;73:1100–1112
  128. Ruppersberg JP, Stocker M, Pongs O, et al.  Regulation of fast inactivation of cloned mammalian IK(A) channels by cysteine oxidation. Nature. 1991;352:711–714
  129. Yuan JX-J. Mechanisms of hypoxic pulmonary vasoconstriction: The role of oxygen-sensitive voltage-gated potassium channels. In:  López-Barneo J,  Weir EK editor. Oxygen regulation of ion channels and gene expression. Chap 17:Armonk, NY: Futura Publishing; 1998;p. 207–233
  130. Yuan X-J, Tod ML, Rubin LJ, et al.  Deoxyglucose and reduced glutathione mimic effects of hypoxia on K+ and Ca2+ conductances in pulmonary artery cells. Am J Physiol Lung Cell Mol Physiol. 1994;267:L52–L63
  131. Miller MA, Hales CA. Role of cytochrome P-450 in alveolar hypoxic pulmonary vasoconstriction in dogs. J Clin Invest. 1979;64:666–673
  132. Sylvester JT, McGowan C. The effects of agents that bind to cytochrome P-450 on hypoxic pulmonary vasoconstriction. Circ Res. 1978;43:429–437
  133. Chang SW, Dutton D, Wang HL, et al.  Intact lung cytochrome P-450 is not required for hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol. 1992;263:L446–L453
  134. Stanbrook HS, McMurtry IF. Inhibition of glycolysis potentiates hypoxic vasoconstriction in rat lungs. J Appl Physiol. 1983;55:1467–1473
  135. Rounds S, McMurtry IF. Inhibitors of oxidative ATP production cause transient vasoconstriction and block subsequent pressor responses in rat lungs. Circ Res. 1981;48:393–400
  136. Platoshyn O, Yu Y, Golovina VA, et al.  Chronic hypoxia decreases Kv channel expression and function in pulmonary artery myocytes. Am J Physiol Lung Cell Mol Physiol. 2001;280:L801–L812
  137. Wang J, Juhaszova M, Rubin LJ, et al.  Hypoxia inhibits gene expression of voltage-gated K+ channel α subunits in pulmonary artery smooth muscle cells. J Clin Invest. 1997;100:2347–2353
  138. Semenza GL. Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res. 2000;1:159–162
  139. Michiels C, Arnould T, Remacle J. Endothelial cell responses to hypoxia: Initiation of a cascade of cellular interactions. Biochim Biophys Acta. 2000;1497:1–10
  140. Lawson CA, Yan SD, Yan SF, et al.  Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J Clin Invest. 1997;99:1729–1738
  141. Yu AY, Frid MG, Shimoda LA, et al.  Temporal, spatial and oxygen-regulated expression of hypoxia-inducible factor 1 in the lung. Am J Physiol Lung Cell Mol Physiol. 1998;275:L818–L826
  142. Chen YF, Oparil S. Endothelin and pulmonary hypertension. J Cardiovasc Pharmacol. 2000;35:S49–S53
  143. Richard DE, Berra E, Pouyssegur J. Non-hypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J Biol Chem. 2000;275:26765–26771
  144. Yuan JX-J, Rubin LJ. Altered expression and function of KV channels in primary pulmonary hypertension. In:  Archer SL,  Rusch NJ editor. Potassium Channels in Cardiovascular Biology. New York, NY: Kluwer Academic/Plenum Publishers; 2001;p. 821–836
  145. Abenhaim L, Moride Y, Brenot F, et al.  Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 1996;335:609–616
  146. Weir EK, Reeve HL, Huang JMC, et al.  Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Circulation. 1996;94:2216–2220
  147. Lane KB, Machado RD, Pauciulo MW, et al.  Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet. 2000;26:81–84
  148. Massague J, Chen Y-G. Controlling TGF- β signaling. Genes Devel. 2000;14:627–644
  149. Yu Y, Platoshyn O, Zhang J, et al.  c-Jun decreases voltage-gated K+ channel activity in pulmonary artery smooth muscle cells. Circulation. 2001;104:1557–1563
  150. Schott R, Chaouat A, Launoy A, et al.  Improvement of pulmonary hypertension after liver transplantation. Chest. 1999;115:1748–1749
  151. Rothman RB, Ayestas MA, Dersch CM, et al.  Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. Circulation. 1999;100:869–875
  152. Eddahibi S, Raffestin B, Pham I, et al.  Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. Am J Physiol Heart Circ Physiol. 1997;272:H1173–H1181
  153. Eddahibi S, Fabre V, Boni C, et al.  Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cell. Relationship with the mitogenic action of serotonin. Circ Res. 1999;84:329–336
  154. Eddahibi S, Hanoun N, Lanfumey L, et al.  Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest. 2000;105:1555–1562
  155. Nakaki T, Nakayama M, Yamamoto S, et al.  α1-Adrenergic stimulation and β2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol. 1990;37:30–36
  156. Pitt BR, Weng W, Steve AR, et al.  Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am J Physiol Lung Cell Mol Physiol. 1994;266:L178–L186

☆ Supported in part by grants from the National Institutes of Health (HL 54043, HL 64945, HL 66012, and HL 69758). and the American Heart Association.

☆☆ Address reprint rquests to Jason X.-J. Yuan, MD, PhD, Division of Pulmonary and Critical Care Medicine, UCSD Medical Center, 200 W. Arbor Dr, San Diego, CA 92103-8382.

PII: S0033-0620(02)70001-7

doi: 10.1053/pcad.2002.127491

Progress in Cardiovascular Diseases
Volume 45, Issue 2 , Pages 81-114 , September 2002

Article Tools

* Image Usage & Resolution